Pharmaceutical companies just raised list prices for over 500 medicines, including Novo Nordisk’s Ozempic, Gilead’s HIV-1 ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Livdelzi will launch at a list price of $12,606 for a 30-day treatment ... Seigerman predicted peak sales of $847 million for Gilead's drug. Both the PPAR drugs compete with Intercept Pharma's ...